Absorption, distribution and excretion of the new thienopyridine agent prasugrel in rats.
Xenobiotica
; 37(7): 788-801, 2007 Jul.
Article
em En
| MEDLINE
| ID: mdl-17620223
ABSTRACT
Prasugrel is converted to the pharmacologically active metabolite after oral dosing in vivo. In this study, (14)C-prasugrel or prasugrel was administered to rats at a dose of 5 mg kg(-1). After oral and intravenous dosing, the values of AUC(0-infinity) of total radioactivity were 36.2 and 47.1 microg eqx h ml(-1), respectively. Oral dosing of unlabeled prasugrel showed the second highest AUC(0-8) of the active metabolite of six metabolites analyzed. Quantitative whole body autoradiography showed high radioactivity concentrations in tissues for absorption and excretion at 1 h after oral administration, and were low at 72 h. The excretion of radioactivity in the urine and feces were 20.2% and 78.7%, respectively, after oral dosing. Most radioactivity after oral dosing was excreted in bile (90.1%), which was reabsorbed moderately (62.4%). The results showed that orally administered prasugrel was rapidly and fully absorbed and efficiently converted to the active metabolite with no marked distribution in a particular tissue.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Piperazinas
/
Piridinas
/
Tiofenos
/
Antagonistas do Receptor Purinérgico P2
/
Absorção Intestinal
Limite:
Animals
Idioma:
En
Revista:
Xenobiotica
Ano de publicação:
2007
Tipo de documento:
Article